Moderna's mRNA flu vaccine is cleared for older adults as Canada allows an Ebola trial
The United States approved Moderna's mRNA influenza vaccine for people 50 and older, and Health Canada authorized a clinical trial of an mRNA vaccine for the Bundibugyo Ebola strain.